IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen



Status:Active, not recruiting
Conditions:Prostate Cancer, Cancer, Hematology, Urology
Therapuetic Areas:Hematology, Nephrology / Urology, Oncology
Healthy:No
Age Range:18 - 99
Updated:1/13/2019
Start Date:May 4, 2011
End Date:July 31, 2022

Use our guide to learn which trials are right for you!

A Multicenter, Open-label, Single-arm, Phase 2 Study of Abiraterone Acetate Plus Prednisone in Subjects With Advanced Prostate Cancer Without Radiographic Evidence of Metastatic Disease

The purpose of this study is to show that abiraterone acetate plus prednisone added to the
current standard of care, gonadotropin-releasing hormone (GnRH) decreases prostate specific
antigen (PSA) and prolongs the time until it is evident that the cancer has grown.
Additionally, safety information about abiraterone acetate in combination with prednisone
will be collected. This will include looking at what side effects occur, how often they
occur, and for how long they last.

This is a Phase 2, prospective, multicenter, open-label, single-arm study of abiraterone
acetate plus prednisone in men with non-metastatic, castration-resistant prostate cancer
(CRPC) who have a rising PSA despite castrate levels of testosterone. The study consists of
Screening Phase (up to 4 weeks), Core Study Treatment Phase (comprised of six 28-day cycles),
a Pre-metastatic Disease Follow-up Phase, an Optional Drug Holiday Phase; and a 30-day Safety
Follow-up Visit. Each treatment cycle will last 28 days. Participating participants will
receive study agents (Abiraterone acetate 1000 mg/day plus prednisone 5 mg/day, orally)
continually during the study. If the partcipants elects to participate in the Optional Drug
Holiday Phase, participants will discontinue abiraterone acetate plus prednisone and ADT.
Participants will have the option to return to study medication during the first year of the
Optional Drug Holiday Phase if there is evidence of rising PSA but no metastasis based on
study imaging. If participants do no elect to participate, they will continue with the core
study treatment as per protocol. The study will end when all participated participants have
disease progression or end of the 2-year period (if participants participated in the Optional
Drug Holiday Phase). Participants will be required to return to the study site 30 days after
receiving the last dose of abiraterone acetate for safety follow-up.

Major Inclusion Criteria:

- Be a male >= 18 years of age

- Have adenocarcinoma of the prostate

- Currently receiving continuous treatment with Gonadotropin-releasing hormone (GnRH)
monotherapy for at least 6 months before or have undergone surgical removal of the
testicles

- Serum testosterone of < 50 ng/dL(< 2.0 nM)

- Have rising PSA defined as a PSA of >= 10 ng/mL obtained at screening or PSADT of ≤ 10
months with the first of the 3 consecutive PSA values used to calculate PSADT ≥ 2.0
ng/mL

- Have an Eastern Cooperative Oncology Group (ECOG) performance status less than or
equal to 2

- Be capable of swallowing study agents whole as a tablet

- Be willing/able to adhere to the prohibitions and restrictions specified in this
protocol

Major Exclusion Criteria:

- Have prior or current evidence of local disease progression or metastatic disease as
defined by modified response evaluation criteria in solid tumors (RECIST) criteria

- Have received chemotherapy for treatment of castrate-resistant prostate cancer;
however, if a patient received chemotherapy in an adjuvant setting, prior to having
CRPC, for castrate-sensitive prostate cancer, the patient is still eligible

- Are currently receiving any antiandrogen therapy (eg, bicalutamide, flutamide, or
nilutamide).

- If previously treated with antiandrogen therapy, there must be documentation of at
least 2 consecutive rising PSA values at least 2 weeks apart obtained prior to
screening

- If previously treated with flutamide, at least 1 of the PSA values must be obtained 4
weeks or more after flutamide discontinuation.

- If previously treated with bicalutamide or nilutamide, at least 1 of the PSA values
must be obtained 6 weeks or more after antiandrogen discontinuation

- Have previously received agents having any CYP17 inhibitory activity for the treatment
of prostate cancer, such as ketoconazole

- Have previously received aminoglutethimide

- Have an active infection or other medical condition that would contraindicate
prednisone use

- Have uncontrolled hypertension

- Have active hepatitis or chronic liver disease

- Have clinically significant heart disease

- Have poorly controlled diabetes

- Have received an investigational therapeutic within 30 days of screening

- Have partners of childbearing potential and are not willing to use a method of birth
control with adequate barrier protection as determined to be acceptable by the
principal investigator and sponsor during the study and for 1 week after last dose of
abiraterone acetate.

- Individuals with a history of a non-prostate malignancy are ineligible for this study
with the following exceptions. Individuals with a history of other malignancies are
eligible if they have been disease-free for at least 3 years and are deemed by the
investigator to be at low risk for recurrence of that malignancy. Individuals with the
following cancers are eligible if diagnosed and treated within the past 3 years: basal
cell or squamous cell carcinoma of the skin
We found this trial at
45
sites
?
mi
from
Albany, NY
Click here to add this to my saved trials
?
mi
from
Arlington, TX
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Aurora, CO
Click here to add this to my saved trials
?
mi
from
Aventura, FL
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Boston, MA
Click here to add this to my saved trials
?
mi
from
Brooklyn, NY
Click here to add this to my saved trials
?
mi
from
Buffalo, NY
Click here to add this to my saved trials
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
?
mi
from
Denver, CO
Click here to add this to my saved trials
?
mi
from
Evanston, IL
Click here to add this to my saved trials
?
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
?
mi
from
Galesburg, IL
Click here to add this to my saved trials
?
mi
from
Garden City, NY
Click here to add this to my saved trials
?
mi
from
Glenview, IL
Click here to add this to my saved trials
Greenville, South Carolina 29605
?
mi
from
Greenville, SC
Click here to add this to my saved trials
?
mi
from
Homewood, AL
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Huntsville, AL
Click here to add this to my saved trials
?
mi
from
Jeffersonville, IN
Click here to add this to my saved trials
?
mi
from
Lancaster, PA
Click here to add this to my saved trials
?
mi
from
Lansing, MI
Click here to add this to my saved trials
LawrenceVille, New Jersey 08648
?
mi
from
LawrenceVille, NJ
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Melrose Park, IL
Click here to add this to my saved trials
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Myrtle Beach, South Carolina 29572
?
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Omaha, NE
Click here to add this to my saved trials
?
mi
from
Orange City, FL
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
?
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
?
mi
from
Raleigh, NC
Click here to add this to my saved trials
?
mi
from
Rockville, MD
Click here to add this to my saved trials
?
mi
from
San Diego, CA
Click here to add this to my saved trials
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
?
mi
from
Seattle, WA
Click here to add this to my saved trials
?
mi
from
Staten Island, NY
Click here to add this to my saved trials
?
mi
from
Tucson, AZ
Click here to add this to my saved trials